Evidence of ABL-kinase domain mutations in highly purified primitive stem cell populations of patients with chronic myelogenous leukemia. [electronic resource]
Producer: 20041209Description: 728-30 p. digitalISSN:- 0006-291X
- Antineoplastic Agents -- administration & dosage
- Benzamides
- Cell Differentiation -- drug effects
- Cells, Cultured
- Drug Resistance -- genetics
- Enzyme Inhibitors -- administration & dosage
- Fusion Proteins, bcr-abl -- genetics
- Gene Expression Regulation, Neoplastic -- drug effects
- Genetic Predisposition to Disease -- genetics
- Genetic Testing -- methods
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Mutation
- Phosphotransferases -- antagonists & inhibitors
- Piperazines -- administration & dosage
- Protein Structure, Tertiary
- Pyrimidines -- administration & dosage
- Sequence Analysis, Protein
- Stem Cells -- drug effects
- Structure-Activity Relationship
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Comparative Study; Evaluation Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.